1824
M. Colonna et al. / Polymer 53 (2012) 1823e1830
of permeability with consequent cell death and therefore present
the strongest bactericidal properties [16]. Imidazolium salt deriv-
atives have also been used in the last few years in several biological
and material science applications and represent a very interesting
class of functional polymers for advanced applications. For
example, a recent review [17] reports that polyimidazoles can be
used as oxygen transport membranes [18] or as scaffold for
biomimetic applications [19]. Imidazolium ionomers can also be
used to create polyelectrolyte brushes [20], coat metal nano-
particles [21] and produce oriented liquid crystals [22]. Imidazo-
lium derivatives have been used in most applications as additives
blended with the polymer matrix [15].
We have recently reported [13] the synthesis and the study of
AM properties of imidazolium telechelic PBT (with ionic moieties
selectively located as chain ends). Imidazolium ionomers have
proved to have good AM properties [13] with a 97.5% reduction of
viable cells of S. aureus and a 48.5% of Escherichia coli in 24 h.
However, the synthesis of the monomer used to prepare the tel-
echelic imidazolium ionomer needs several steps with long reac-
tion times (over 70 h for the monomer synthesis) [13] and for this
reason we have started the study of alternative synthetic
strategies.
The synthesis of PBT ionomers with sulfonated groups is widely
reported in the literature [23e25] and consists in the addition of
a sulfonated aromatic salt containing one or two carboxylic acid or
ester moieties during a standard polycondensation process. The
cation of the sulfobenzoic acid derivative can be easily exchanged
with other cations such as imidazolium cations [26]. The prepara-
tion of the imidazolium ionic monomer in this case is easier and
requires less expensive reactants [23e25] with respect to the
monomer used for the covalent bond of the imidazolium that we
have recently reported [13]. With this approach, the imidazolium
group is ionically linked to the sulfonate group covalently inserted
in the polymer chain. However, since the ionic groups are not
covalently bonded to the polymer chain, a higher mobility with
respect to the covalent linking previously reported [13] of the AM
agent should be expected, especially in the presence of water and
moisture. For this reason, a study of long-term AM activity is also
crucial in order to verify the possible decrease of AM activity during
use. Moreover, the use of this new synthetic strategy can also allow
the preparation of random ionomers in which the ionic groups are
randomly distributed along the polymer chain. The comparison
between random and telechelic ionomers AM activities is also of
interest since permits to better understand the effect of the position
of imidazolium groups thus understanding the best polymer
architecture to be used in industrial AM applications.
2.2. Monomer synthesis
2.2.1. 1-hexadecyl-3-methyl imidazolium bromide synthesis
1-methylimidazole (8.21 g, 0.100 mol) and 1-bromohexadecane
(32.1 g, 0.105 mol) were dissolved in 100 mL of toluene. The solu-
tionwas put under vigorous stirring and refluxed for 6 h. The solvent
was removed under reduced pressure and the solid was washed
twice with ethyl acetate (200 mL each time) and dried under
vacuum. (yield ¼ 99%) 1H NMR (400 MHz, CDCl3/TFA, 4/1,
d, ppm):
0.88 (t, J ¼ 6.8 Hz, 3H, CH3-C15chain), 1.20e1.44 (m, 26H, CH2), 1.89
(m, 2H, CH2eCH2eN), 3.98 (s, 3H, CH3-N), 4.19 (t, J ¼ 7.5 Hz, 2H, CH2-
N), 7.28 (bs, 1H, CH in imidazolium ring), 7.29 (bs, 1H, CH in imida-
zolium ring), 8.70 (s, 1H, NeCHeN in imidazolium ring). 13C NMR
(100 MHz, CDCl3/TFA, 4/1, d, ppm): 13.92 (CH3-C15chain), 22.73,
26.22, 28.91, 29.34, 29.44, 29.51, 29.63, 29.70, 29.74, 29.76, 30.15,
32.01 (CH2), 36.59 (CH3-N), 50.68 (CH2-N), 122.30, 123.76, (CH in
imidazolium ring), 135.78 (NeCHeN in imidazolium ring).
2.2.2. 3-sulfobenzoic acid 1-hexadecyl-3-methyl imidazolium salt
(Im-SBA) synthesis
1-hexadecyl-3-methyl imidazolium
bromide
(5.00 g,
0.0129 mol) was dissolved in 65 mL of dichloromethane (DCM) and
added to a solution of sulfobenzoic acid sodium salt (3.18 g,
0.0142 mol) dissolved in 50 mL of water in a separating funnel. The
content of the funnel was vigorously shaken for 5 min until no
precipitate was present in the resulting two-phase mixture. The
organic layer was separated and a silver nitrate test was performed
to verify the complete exchange of the bromide counter-ion. If the
exchange was not complete, the organic layer was exchanged with
a new water solution containing the sulfobenzoic acid salt. The
organic layer was separated, dried over magnesium sulfate and the
solvent removed under reduced pressure. The yellow solid was
washed twice with ethyl acetate (100 mL each time). The product
was dried under vacuum (yield ¼ 95%). 1H NMR (400 MHz, CDCl3/
TFA, 4/1,
d, ppm): 0.88 (t, J ¼ 6.9 Hz, 3H, CH3-C15chain), 1.20e1.40
(m, 26H, CH2), 1.88 (t, J ¼ 7.1 Hz 2H, CH2eCH2eN), 3.97 (s, 3H,
CH3-N), 4.18 (t, J ¼ 7.5 Hz, 2H, CH2-N), 7.29 (dd, J1 ¼ 1.6 Hz,
J2 ¼ 1.7 Hz, 1H, CH in imidazolium ring), 7.31 (dd, J1 ¼ 1.6 Hz,
J2 ¼ 1.6 Hz, 1H, CH in imidazolium ring), 7.64 (dd, J1 ¼ 7.9 Hz,
J2 ¼ 8.0 Hz, 1H, CH in benzene ring, meta-position with respect to
COOH substituent), 8.17 (dd, J1 ¼ 7.9 Hz, J2 ¼ 1.6 Hz, J3 ¼ 1.2 Hz, 1H,
CH in benzene ring, ortho-position with respect to COOH substit-
uent), 8.26 (dd, J1 ¼7.9 Hz, J2 ¼ 1.6 Hz, J3 ¼ 1.1 Hz, 1H, CH in benzene
ring, ortho-position with respect to SO3 substituent), 8.52 (s, 1H,
NeCHeN in imidazolium ring), 8.56 (dd, J1 ¼1.6 Hz, J2 ¼ 1.5 Hz, 1H,
CH in benzene ring, ortho-position between COOH and SO3
In this paper we report for the first time the synthesis and the
characterization of two new imidazolium ionomers together with
the first study of the AM activity of different polymer architectures
(random or telechelic) and linkages (covalent or ionic) of the imi-
dazolium groups to the polymer chain. We also report the long-
term antimicrobial properties after immersion in water for 6 days
at 60 ꢀC of imidazolium PBT ionomers in comparison to a tradi-
tional AM agent.
substituents). 13C NMR (100 MHz, CDCl3/TFA, 4/1,
d, ppm): 13.91
(CH3-C15chain), 22.70, 26.15, 28.85, 29.30, 29.40, 29.47, 29.59,
29.66, 29.70, 29.72, 30.04, 31.97 (CH2), 36.30 (CH3-N), 50.52 (CH2-
N), 122.38, 123.87 (CH in imidazolium ring), 127.89 (CH in benzene
ring, ortho-position between COOH and SO3 substituents), 129.00
(C-COOH), 129.62, 131.85, 133.65 (CH in benzene ring), 135.38
(NeCHeN in imidazolium ring), 142.22 (C-SOꢁ3 ), 171.30 (COOH).
2.2.3. Dimethyl-5-sulfoisophthalate 1-hexadecyl-3-methyl
imidazolium salt (Im-DMSIP) synthesis
2. Experimental
1-hexadecyl-3-methyl
imidazolium
bromide
(10.0
g,
2.1. Materials
0.0258 mol) was dissolved in 130 mL of dichloromethane (DCM) and
added to a solution of dimethyl-5-sulfoisophthalate sodium salt
(8.02 g, 0.0271 mol) dissolved in 400 mL of water in a separating
funnel. The content of the funnel was vigorously shaken for 5 min
until no precipitate was present in the resulting two-phase mixture.
The organic layer was separated and a silver nitrate test was per-
formed to verify the complete exchange of the bromide counter-ion.
If the exchange was not complete, the organic layer was exchanged
Potassium hydroxide, 1-methylimidazole, 1-bromohexadecane,
1,4-butanediol (BD), dimethyl terephthalate (DMT), titanium tet-
rabutoxide, dichloromethane, 3-sulfobenzoic acid sodium salt,
dimethyl-5-sulfoisophthalate sodium salt and Triclosan (5-chloro-
2-(2,4-dichlorophenoxy)phenol) (all from Aldrich Chemicals) were
high purity products and were not purified before use.